Fund HoldingsvenBio Partners LLC

Total Portfolio Value
$114.76M
Total Bought
$7.44M
Total Sold
$15.08M
Net Transaction
-$7.64M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
PHARVARIS N V
COM
4,289,3044,289,304067,34275,49265.78%+8,150
LYELL IMMUNOPHARMA INC0473,479+473,47904,1863.65%+4,186
HARMONY BIOSCIENCES HLDGS IN(HRMY)489,194489,194016,23615,45913.47%-778
ARTIVA BIOTHERAPEUTICS INC1,198,9751,148,975-50,0003,5971,7351.51%-1,862
ALX ONCOLOGY HLDGS INC9,699,9259,699,92506,0434,0263.51%-2,017
ALUMIS INC2,787,3984,619,803+1,832,40517,11513,85912.08%-3,255
LYELL IMMUNOPHARMA INC7,102,1900-7,102,1903,8210-3,821
ACELYRIN INC3,806,4100-3,806,4109,4020-9,402
Page 1 of 1